Detected ·
ImpriMed, Inc.
——
ImpriMed, Inc., a precision oncology startup analyzing patients' live cancer cells to guide chemotherapy decisions, announced NAVER D2SF has joined as a new investor, with LB Investment leading the round.
- Website
- www.imprimedicine.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-21 00:03:32 UTC
- Signal ID
- 529a964a-637d-40bf-a991-6ab43f7ed740
As the API returns it
{
"id": "529a964a-637d-40bf-a991-6ab43f7ed740",
"created_at": "2026-09-21T00:03:32.395083Z",
"company_name": "ImpriMed, Inc.",
"company_website_url": "www.imprimedicine.com",
"company_linkedin_url": "https://www.linkedin.com/company/imprimed-inc",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*ImpriMed, Inc., a precision oncology startup analyzing patients' live cancer cells to guide chemotherapy decisions, announced NAVER D2SF has joined as a new investor, with LB Investment leading the round.*"
}